Exact Mass: 614.0878476
Exact Mass Matches: 614.0878476
Found 63 metabolites which its exact mass value is equals to given mass value 614.0878476,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Castacrenin A
Castacrenin A is found in nuts. Castacrenin A is a constituent of the heartwood of Castanea crenata (Japanese chestnut)
2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose
2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is found in green vegetables. 2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is isolated from commercial rhubarbs (Rheum sp.). Isolated from commercial rhubarbs (Rheum species). 2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is found in green vegetables.
Castacrenin C
Castacrenin C is found in nuts. Castacrenin C is a constituent of the heartwood of Castanea crenata (Japanese chestnut)
6-Cinnamoyl-1,2-digalloylglucose
6-Cinnamoyl-1,2-digalloylglucose is found in green vegetables. 6-Cinnamoyl-1,2-digalloylglucose is isolated from commercial rhubarbs (Rheum species). Isolated from commercial rhubarbs (Rheum subspecies). 6-Cinnamoyl-1,2-digalloylglucose is found in green vegetables.
Castacrenin B
Castacrenin B is found in nuts. Castacrenin B is a constituent of the heartwood of Castanea crenata (Japanese chestnut)
Fosaprepitant
Fosaprepitant is only found in individuals that have used or taken this drug. It is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment.Aprepitant has been shown in animal models to inhibit emesis induced by cytotoxic chemotherapeutic agents, such as cisplatin, via central actions. Animal and human Positron Emission Tomography (PET) studies with Aprepitant have shown that it crosses the blood brain barrier and occupies brain NK1 receptors. Animal and human studies show that Aprepitant augments the antiemetic activity of the 5-HT3-receptor antagonist ondansetron and the corticosteroid ethasone and inhibits both the acute and delayed phases of cisplatin induced emesis.In summary, the active form of fosaprepitant is as an NK1 antagonist which is because it blocks signals given off by NK1 receptors. This therefore decreases the likelihood of vomiting in patients experiencing. D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
Lifitegrast
1-Hydroxycrisamicin A
An organic heterotetracyclic compound isolated from the culture broth of Micromonospora sp. SA-246. It exhibits potent antibacterial activity against several Gram-positive bacterial strains.
4-galloyl-3,3-di-O-methylellagic acid 4-O-beta-D-xylopyranoside
3-methoxy-7-O-beta-(6-galloylglucopyranoside)quercetin
Fosaprepitant
D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
Castacrenin A
Castacrenin B
Castacrenin C
2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose
6-Cinnamoyl-1,2-digalloylglucose
Lifitegrast
D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions C78283 - Agent Affecting Organs of Special Senses S - Sensory organs > S01 - Ophthalmologicals
2,7-Dibromo-9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-9H-fluorene
6-[1-(7-Chloro-3,5,6,8-tetramethoxy-4-oxochromen-2-yl)-3-methoxy-4-oxocyclohexa-2,5-dien-1-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
2-deoxycytidine 5-monophosphate dimer
A cyclobutadipyrimidine bis(deoxyribonucleotide) obtained by formal cyclodimerisation of 2-deoxycytidine 5-monophosphate.
5,6-diamino-1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-4,5-dihydro[4,4-bipyrimidine]-2,2(1H,3H)-dione
An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.
1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-6-(5,6-diamino-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl)-1,3-diazabicyclo[2.2.0]hex-4-en-2-one
An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.
(E)-Akt inhibitor-IV
(E)-Akt inhibitor-IV ((E)-AKTIV) is a PI3K-Akt inhibitor, with potent cytotoxic[1].
(11s,15s,17r)-7,17-dihydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione
7'-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-7-hydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione
3,5-dihydroxy-2-{3-hydroxy-4-[2-methoxy-4-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]phenyl}-7-methoxychromen-4-one
5-[4-(1,2-dihydroxyethyl)-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione
17-methyl-5-{2,7,9-trihydroxy-17-methyl-13-oxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1,3,5,7,9-pentaen-5-yl}-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),5-triene-2,4,7,9,13-pentone
(1s,2s,4r,12s,13r,15r,16s)-2-bromo-8-[(2r,3s)-1,1-dichloro-3-hydroxy-3-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]propan-2-yl]-16-hydroxy-9,13-dimethyl-18-oxapentacyclo[13.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰]octadeca-5(10),6,8-triene-11,17-dione
7,14-dimethoxy-3,10-dioxo-13-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaen-6-yl 3,4,5-trihydroxybenzoate
1,6-digalloyl-2-cinnamoyl-glucose
{"Ingredient_id": "HBIN001857","Ingredient_name": "1,6-digalloyl-2-cinnamoyl-glucose","Alias": "1-O,6-O-Digalloyl-2-O-cinnamoyl-beta-D-glucopyranose; [(2R,3S,4S,5R,6S)-3,4-dihydroxy-5-[(E)-3-phenylprop-2-enoyl]oxy-6-(3,4,5-trihydroxybenzoyl)oxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate; AC1O3D78","Ingredient_formula": "C29H26O15","Ingredient_Smile": "C1=CC=C(C=C1)C=CC(=O)OC2C(C(C(OC2OC(=O)C3=CC(=C(C(=C3)O)O)O)COC(=O)C4=CC(=C(C(=C4)O)O)O)O)O","Ingredient_weight": "614.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15054","TCMID_id": "5513","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "6325082","DrugBank_id": "NA"}